Labege, France

Simon Leiris

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Simon Leiris: Innovator in Antibacterial Treatments

Introduction

Simon Leiris, situated in Labege, France, is a notable inventor with a focus on pharmaceutical innovations. With a portfolio of five patents, Leiris has made significant contributions to the field of antibacterial treatments. His work primarily revolves around the development of indane derivatives that hold promise for medical applications.

Latest Patents

One of Simon Leiris' latest patents involves the creation of indane derivatives for the treatment of bacterial infections. The invention details an indane compound represented by a specific formula, wherein the components are defined in the documentation. These compounds demonstrate utility in treating antibacterial infections, both as standalone antibiotics and in conjunction with other antibiotics. This innovative approach is crucial in addressing the growing concern of antibiotic resistance.

Career Highlights

Leiris is affiliated with Antabio SAS, a company recognized for its dedication to developing novel antibacterial therapies. His role within this company has allowed him to continue refining his inventive processes and contribute to cutting-edge research in the pharmaceutical domain.

Collaborations

Throughout his career, Simon Leiris has collaborated with esteemed professionals in the field, including David Thomas Davies and Martin Everett. Such partnerships have fostered an environment of shared knowledge and innovation, further enhancing the impact of their collective work in antibacterial research.

Conclusion

In summary, Simon Leiris stands out as an influential inventor in the realm of antibacterial treatments. His recent patents underscore his commitment to developing effective solutions to combat bacterial infections. With a strong collaborative spirit and a foundation in a forward-thinking company like Antabio SAS, Leiris is poised to make significant strides in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…